
Agastya Biopharm India Limited
Develops and manufactures drugs and conducts research in medical sciences for new techniques.
Develops and manufactures drugs and conducts research in medical sciences for new techniques.
Agastya Biopharm India Limited (ABIL) is a Public Limited Indian Non-Government Company incorporated in India on 30 May 2005 and has a history of 19 years and 11 months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 4.25 M, as per Ministry of Corporate Affairs (MCA) records.
Oduvangad Gopalakrishnan, Sidharthan Asan, Karthikeyan Gopalan, and Two other members serve as directors at the Company.
Bangaluru, Karnataka, India
+91-XXXXXXXXXX
U24231KA2005PLC036421
036421
Public Limited Indian Non-Government Company
30 May 2005
30 Sep 2023
31 Mar 2023
Unlisted
Roc Bangalore
Name | Designation | Appointment Date | Status |
---|---|---|---|
Oduvangad Gopalakrishnan ![]() | Director | 23-Oct-2007 | Current |
Sidharthan Asan ![]() | Whole-Time Director | 15-Feb-2012 | Current |
Karthikeyan Gopalan ![]() | Director | 31-Dec-2009 | Current |
Madhu Ganghadharan ![]() | Director | 10-Jan-2011 | Current |
Radhakrishnan Sekharan ![]() | Director | 12-Aug-2011 | Current |
Agastya Biopharm India Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2017, Agastya Biopharm India had a promoter holding of 25.61% and a public holding of 74.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Agastya Biopharm India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Agastya Biopharm India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agastya Biopharm India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Agastya Biopharm India Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Agastya Biopharm India Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
Sidharthan Kochukrishnan Asan was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 15 Feb 2012 & has been associated with this company since 13 years 3 months .
Radhakrishnan Sekharan was appointed as a Director was appointed as a Director on 12 Aug 2011 & has been associated with this company since 13 years 9 months .
Madhu Ganghadharan was appointed as a Director was appointed as a Director on 10 Jan 2011 & has been associated with this company since 14 years 4 months .
Karthikeyan Gopalan was appointed as a Director was appointed as a Director on 31 Dec 2009 & has been associated with this company since 15 years 4 months .
Agastya Biopharm India Limited was incorporated on 30 May 2005.
The authorized share capital of Agastya Biopharm India Limited is ₹ 10.00 Cr and paid-up capital is ₹ 4.25 M.
Currently 5 directors are associated with Agastya Biopharm India Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Agastya Biopharm India Limited is Building No 732 S.N. Plaza ( Anugraha Lodge ) Hmt Main Road, Mathikkara India, Bangalore, Karnataka, 560054.
The corporate identification number (CIN) of Agastya Biopharm India Limited is U24231KA2005PLC036421 and the company number is 036421 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Agastya Biopharm India Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
DA
VS
RJ